Darlinghurst, NEW%20SOUTH%20WALES2 Active Studies

Ankylosing Spondylitis Clinical Trials in Darlinghurst, NEW%20SOUTH%20WALES

Find 2 actively recruiting ankylosing spondylitis clinical trials in Darlinghurst, NEW%20SOUTH%20WALES. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
158
Enrolling

Recruiting Ankylosing Spondylitis Studies in Darlinghurst

About Ankylosing Spondylitis Clinical Trials in Darlinghurst

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 2 ankylosing spondylitis clinical trials recruiting participants in Darlinghurst, NEW%20SOUTH%20WALES. These studies are seeking a combined 158 participants. Research is being sponsored by Gilead Sciences, Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Darlinghurst — FAQ

Are there ankylosing spondylitis clinical trials in Darlinghurst?

Yes, there are 2 ankylosing spondylitis clinical trials currently recruiting in Darlinghurst, NEW%20SOUTH%20WALES. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Darlinghurst?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Darlinghurst research site will contact you about next steps.

Are clinical trials in Darlinghurst free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Darlinghurst studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 2 active trials in Darlinghurst are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov